Details for Patent: 9,226,892
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,226,892 protect, and when does it expire?
Patent 9,226,892 protects VAZALORE and is included in one NDA.
This patent has twenty patent family members in nine countries.
Summary for Patent: 9,226,892
Title: | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Abstract: | Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia. |
Inventor(s): | Marathi; Upendra K. (Houston, TX), Childress; Susann Edler (Houston, TX), Gammill; Shaun L. (Houston, TX), Strozier; Robert W. (Houston, TX) |
Assignee: | PLX PHARMA INC. (Houston, TX) |
Application Number: | 13/791,189 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,226,892
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plx Pharma | VAZALORE | aspirin | CAPSULE;ORAL | 203697-001 | Jan 14, 2013 | OTC | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT/PREVENTION OF CARDIOVASCULAR DISEASE | See Plans and Pricing | ||||
Plx Pharma | VAZALORE | aspirin | CAPSULE;ORAL | 203697-001 | Jan 14, 2013 | OTC | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TEMPORARY RELIEF OF MINOR ACHES AND PAINS | See Plans and Pricing | ||||
Plx Pharma | VAZALORE | aspirin | CAPSULE;ORAL | 203697-001 | Jan 14, 2013 | OTC | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TEMPORARY REDUCTION OF FEVER | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,226,892
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2012315545 | See Plans and Pricing | |||
Canada | 2850187 | See Plans and Pricing | |||
China | 103957888 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |